{"id":"W2749614740","doi":"10.1093/jjco/hyx114","title":"A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer","year":2017,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Liver physiology and pathology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Amgen Canada; Amgen","keywords":"Medicine; Capecitabine; Tolerability; Internal medicine; Adverse effect; Gastroenterology; Cancer; Cisplatin; Nausea; Pharmacokinetics; Phases of clinical research; Chemotherapy; Oncology; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001960821,0.0001519418,0.001577995,0.0001979984,0.00006050062,0.000004649673,0.0001679628,0.0001893114,0.00005079157],"category_scores_gemma":[0.001812791,0.00008503044,0.00005067053,0.0001733358,0.000509172,0.0002195169,0.00005869816,0.0006920187,7.579679e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008274707,"about_ca_system_score_gemma":0.0003663422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004659936,"about_ca_topic_score_gemma":0.003571136,"domain_scores_codex":[0.9970086,0.0007139865,0.001561193,0.0002590931,0.000247544,0.0002095621],"domain_scores_gemma":[0.9960498,0.001373978,0.001630045,0.0003042606,0.0004791415,0.0001627704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0641261,0.03653589,0.8863825,0.00003396878,0.00009902773,0.0005617038,0.00347573,0.00002016069,0.0001739732,0.000001899684,0.000004515633,0.008584573],"study_design_scores_gemma":[0.1244272,0.08304292,0.7907612,0.0000942017,0.0001307639,0.0001733959,0.001167962,0.00008726796,0.000008969495,0.00003133225,0.00000591659,0.00006891969],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984083,0.00001968975,0.000002092198,0.0007115522,0.0001388829,0.000620903,0.000002686813,0.000002830782,0.00009304863],"genre_scores_gemma":[0.9993711,0.00002547997,0.0003057342,0.0001695399,0.00007758144,0.00001860741,0.000002350745,0.000009203768,0.00002037239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09562126,"threshold_uncertainty_score":0.3467441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08147835014551864,"score_gpt":0.4445169253689405,"score_spread":0.3630385752234219,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}